Occupational Therapists in Kingsburg, CA Accepting Medicare
4 Occupational Therapists found. Showing 1 - 4
 Brittany Marcelle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1101 Stroud Ave, Kingsburg, CA 93631 Phone: 559-897-5881 |
Morgan Inouye, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2560 18th Ave, Kingsburg, CA 93631 Phone: 559-288-0567 |
Megan Alltucker, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1581 18th Ave, Kingsburg, CA 93631 Phone: 559-897-5270 Fax: 559-897-0920 |
Hiliary A Fantasia, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1101 Stroud Ave, Kingsburg, CA 93631 Phone: 315-415-3437 |
News Archive
Emory's Yerkes Research Center receives $9.5M grant to establish research center to study oxytocin
The Yerkes National Primate Research Center, Emory University, has received a five-year, $9.5 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center in Neuroscience Research to study oxytocin, a brain chemical known for forming bonds between mother and baby.
New Health Affairs study reexamines cost issues related to care in McAllen and El Paso
"Did McAllen get a bum rap? McAllen, Texas, spends more on Medicare patients than almost any other part of the country. A June 2009 New Yorker article by Atul Gawande attributed the high spending to a culture of doctors that 'came to treat patients the way sub-prime mortgage lenders treated home buyers: as profit centers.' The article became required reading in the White House and Congress during the health care debate and turned McAllen into shorthand for America's decadent medical spending problem."
New tool helps measure how costs of care impact cancer patients
For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity," the anxiety and distress that follow health care and medication expenses, often compounded by reduced ability to work.
Anesiva to merge with Arcion Therapeutics
Anesiva, Inc. announced today that the stockholders of Anesiva approved the merger with Arcion Therapeutics, Inc. ("Arcion") during its December 3, 2009 shareholder meeting. In connection with the merger, Anesiva stockholders also approved a one-for-forty reverse stock split, which will be effected upon the close of the merger.
RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation
ZymoGenetics, Inc., today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in the February issue of the Journal of the American College of Surgeons. The authors concluded that RECOTHROM is a well-tolerated topical hemostatic agent in numerous surgical settings and has a low rate of anti-product antibody formation. In the pooled data from all trials, less than one percent of treated patients developed product-specific antibodies. None of the antibodies neutralized native coagulation proteins.
› Verified 4 days ago
Physical Therapists
Chiropractors
Optometrists
Speech-Language Pathologists
Occupational Therapists